Inventor · disambiguated record
Miles Andrew Nunn
Also filed as: NUNN MILES · NUNN MILES A · NUNN MILES ANDREW
6 granted patents·12 pending applications·46 citations·filing 2003–2024
81Inventor score
Files withVOLUTION IMMUNO PHARMACEUTICALS SA11AMPLION LTD1NATURAL ENVIRONMENT RES COUNCIL1NUNN MILES A1NUNN MILES ANDREW1
Top patents by PatentIndex Score
18 records- 0189US7914986B2Detection of amplicon contamination during PCR exhibiting two different annealing temperaturesAMPLION LTD·Filed 2005·Granted Mar 29, 2011·33 cites·11 claims
- 0280US11730792B2Coversin (OmCI) for the treatment of autoimmune blistering diseases: bullous pemphigoid (BP) and epidermolysis bullosa acquisita (EBA)VOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2018·Granted Aug 22, 2023·3 cites·21 claims
- 0377US9834585B2Method of inhibiting C5 cleavageVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2015·Granted Dec 5, 2017·2 cites·39 claims
- 0476US2022363726A1Method of Inhibiting C5 CleavageVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2022·Application pending·0 cites
- 0574US2025195612A1Coversin for use in the treatment of rheumatic diseasesVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2024·Application pending·0 cites
- 0672US8993264B2Complement inhibitorsNUNN MILES ANDREW·Filed 2011·Granted Mar 31, 2015·3 cites·23 claims
- 0771US11214602B2Coversin variants lacking C5 bindingVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2018·Granted Jan 4, 2022·1 cites·48 claims
- 0866US7884188B2Complement inhibitorsVARLEIGH IMMUNO PHARM VIP LTD·Filed 2004·Granted Feb 8, 2011·4 cites·19 claims
- 0964US2024009270A1Coversin for the treatment of autoimmune blistering diseasesVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2023·Application pending·0 cites
- 1062US2023002456A1Coversin Variants Lacking C5 BindingVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2021·Application pending·0 cites
- 1162US2022047673A1Coversin for Use in the Treatment of Rheumatic DiseasesVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2019·Application pending·0 cites
- 1257US2018127472A1Method of inhibiting c5 cleavageVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2017·Application pending·0 cites
- 1348US2022370556A1Method of TreatmentVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2019·Application pending·0 cites
- 1441US2021171588A1Methods For Treatment of Neuropathic PainVOLUTION IMMUNO PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 1539US2005090437A1Ion channel modulatorsFiled 2003·Application pending·0 cites
- 1637US2011059885A1Treatment of diseases and conditions mediated by eicosanoidsNATURAL ENVIRONMENT RES COUNCIL·Filed 2009·Application pending·0 cites
- 1728US2017210781A1Polypeptides and uses thereofUNIV OXFORD INNOVATION LTD·Filed 2015·Application pending·0 cites
- 1826US2012115773A1Modified omci as a complement inhibitorNUNN MILES A·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Miles Andrew Nunn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →